Return-Path: Received: from vps.transocean.com by vps.transocean.com with LMTP id uFQAOZ+fw1pxfAAAInt2oQ ; Tue, 03 Apr 2018 08:37:03 -0700 Return-path: Envelope-to: sandyn@transocean.com Delivery-date: Tue, 03 Apr 2018 08:37:03 -0700 Received: from omp.seminar.globalcompliancepanel.com ([129.145.68.201]:56204) by vps.transocean.com with esmtp (Exim 4.89_1) (envelope-from ) id 1f3NzW-0008HY-AM for sandyn@transocean.com; Tue, 03 Apr 2018 08:37:03 -0700 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=globalcompliancepanel; d=seminar.globalcompliancepanel.com; h=MIME-Version:Content-Type:Content-Transfer-Encoding:Date:To:From:Reply-To: Subject:List-Unsubscribe:Message-ID; i=info@seminar.globalcompliancepanel.com; bh=UONhilCtMu9taqZaTRLWKg/LrIzueGWyaqMw5vXcg5k=; b=qHcVFZw/lQrdX6sMo4h3dGMYPYc3C0lYlAdLrFHa3UsNfj+wEpEidh+s069uCWBHYf8sE53CICoe amy2IXM76bA9WgLXPUCSr5pR9WgtmS6j/KZ7bRAiBJ7nXOWELZy4dSbLasHeLukuASR9E0znhNCq v+ZOuxpgZiH6gWnwMr4= Received: by omp.seminar.globalcompliancepanel.com id hoefpk2b610b for ; Tue, 3 Apr 2018 08:36:17 -0700 (envelope-from ) X-CSA-Complaints: whitelist-complaints@eco.de MIME-Version: 1.0 Content-Type: text/html; charset="ISO-8859-1" Content-Transfer-Encoding: quoted-printable Date: Tue, 3 Apr 2018 08:36:17 -0700 To: sandyn@transocean.com From: =?ISO-8859-1?B?UHJvY2VzcyBWYWxpZGF0aW9uIFN0YXRpc3RpY2FsIEFwcHI=?= =?ISO-8859-1?B?b2FjaA==?= Reply-To: =?ISO-8859-1?B?UHJvY2VzcyBWYWxpZGF0aW9uIFN0YXRpc3RpY2FsIEFwcHI=?= =?ISO-8859-1?B?b2FjaA==?= Subject: Applied Statistics for FDA Process Validation Feedback-ID: 10655:101222:oraclersys List-Unsubscribe: , X-sgxh1: kHgKPgxljHgkhJLHgQJhu X-rext: 5.interact2.Eqz8FMD234Sv30iEKl4Fc8SLQkO7r4clowaXj_4ebWGjovpZZKQXuYw0ab4 X-cid: netzealou.45122 Message-ID: <0.1.49.279.1D3CB61821CF3CA.0@omp.seminar.globalcompliancepanel.com> X-Spam-Status: No, score=1.6 X-Spam-Score: 16 X-Spam-Bar: + X-Ham-Report: Spam detection software, running on the system "vps.transocean.com", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Applied Statistics for FDA Process Validation Your Gateway to Regulatory Compliance View Online About Us Webinars($10) Seminars Past Seminar Pictures Use MGCP50 Promo Code to GET FLAT 50% OFF on ALL SEMINARS - Offer Ends Today 2-day In-person Seminar Applied Statistics for FDA Process Validation Click Here for More Details! Overview:In Guidance for Industry Process Validation: General Principle and Practices, process validation is defined as, ""...the collection and evaluation of data, from the process design stage through commercial production.." The guidance further delineates the 'process design stage through commercial production' into three distinct stages of the product lifecycle: [...] Content analysis details: (1.6 points, 3.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: globalcompliancepanel.com] -0.0 SPF_PASS SPF: sender matches SPF record -0.0 T_RP_MATCHES_RCVD Envelope sender domain matches handover relay domain -0.0 BAYES_20 BODY: Bayes spam probability is 5 to 20% [score: 0.0671] 0.0 HTML_MESSAGE BODY: HTML included in message 0.7 MIME_HTML_ONLY BODY: Message only has text/html MIME parts -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain 1.0 FROM_EXCESS_BASE64 From: base64 encoded unnecessarily X-Spam-Flag: NO <=21DOCTYPE html PUBLIC =22-//W3C//DTD XHTML 1=2E0 Transitional//EN=22 =22h= ttp://www=2Ew3=2Eorg/TR/xhtml1/DTD/xhtml1-transitional=2Edtd=22> Applied Statistics for FDA Process Validation <=21-- START OF PRE-HEADER A= REA BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= EFT COLUMN--> <=21-- START OF TEXT--> <=21-- END OF TEXT-->
Your Gateway to Regulatory Compliance View Online
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--><=21-- END OF RIGHT COLUMN-->
<=21-- END OF PRE-HEADER AREA BLOCK--><=21-- START OF HEADER BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= OGO-->
3D=22logo=22
<=21-- END OF LOGO--><=21-- START OF SP= ACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN-->
About Us= Webinars(=2410) Seminars
Past Seminar Picture= s
=
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF HEADER BLOCK--><=21-- START OF FEATURED AREA BLOCK-->
3D=22top
Use MGCP50 Promo Code to GET FLAT 50% O= FF on ALL SEMINARS - Offer Ends Today
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF LEFT COLUM= N--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- START BUTTO= N--> <=21-- END BUTTON-->
2-day In-person Seminar
Applied Statistics for FDA Process Validation
Click Here fo= r More Details=21
<=21-- END OF LEFT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
3D=22bottom
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF FEATURED AREA BLOCK--><=21-- START OF 1/1 (FULL WIDTH) INTRO = TEXT BLOCK-->
<=21-- START OF TEXT--> <=21-- END OF TEXT-->
Overview:In Guidance for Industry= Process Validation: General Principle and Practices, process validation is= defined as, =22=22=2E=2E=2Ethe collection and evaluation of data, from the= process design stage through commercial production=2E=2E=22 The guidance f= urther delineates the 'process design stage through commercial production' = into three distinct stages of the product lifecycle:

Stage 1: Process Design: The c= ommercial manufacturing process is defined during this stage based on knowl= edge gained through development and scale-up activities=2E

Stage 2: Process Qualification= : During this stage, the process design is evaluated to determine if the pr= ocess is capable of reproducible commercial manufacturing=2E

Stage 3: Continued Process Ver= ification: Ongoing assurance is gained during routine production that the p= rocess remains in a state of control=2E Read more=2E=2E=2E
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF 1/1 (FULL WIDTH) INTRO TEXT BLOCK--><=21-- START OF DIVIDER I= MAGE BLOCK-->
3D=22divider
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF DIVIDER IMAGE BLOCK--><=21-- START OF 2/3 AND 1/3 COL RIGHT I= MAGE BLOCK-->
<=21-- START OF LEFT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT--><=21-- START= BUTTON-->
= Date & Time
Date: May 17th & 18th, 2018
Time: 9:00 AM= to 6:00 PM
<=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT--><=21-- START= BUTTON-->
= Venue
Philadelphia, PA
DoubleTree by Hilton Philadelp= hia Airport
3D=22divider
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF DIVIDER IMAGE BLOCK--><=21-- START OF 1/3 AND 2/3 COL LEFT IM= AGE BLOCK-->
<=21-- START OF L= EFT COLUMN-->
3D=22img-160-160=22
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT-->
= Heath Rushing
Co-founder and Principal, Adsurgo
Heath Rushin= g, is the cofounder of Adsurgo and author of the book Desig= n and Analysis of Experiments by Douglas Montgomery: A Supplement for using= JMP=2E Previously, he was the JMP and Six Sigma training manager at SAS=2E= He led a team of nine technical professionals designing and delivering app= lied statistics and quality continuing education courses=2E
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF 1/3 AND 2/3 COL LEFT IMAGE BLOCK--><=21-- START OF CALL TO AC= TION BLOCK-->
3D=22top
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= EFT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING-->
Reserve your Seat Now=21
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--> <=21-- START BUTTON--> <=21-- END BUTTON-->
Enrol= l Now=21
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
3D=22bottom
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF CALL TO ACTION BLOCK--><=21-- START OF SUB-FOOTER BLOCK-->
<=21-- START OF L= EFT COLUMN-->
GlobalComp= liancePanel
161 Mission Falls Lane, Suite = 216, Fremont, CA 94539, USA=2E
Phone: +1-800-447-9= 407
Fax: 302 288 6884<= /td>
www= =2Eglobalcompliancepanel=2Ecom =7C Unsubscribe
Copyright © 2017 GlobalCo= mpliancePanel=2E All rights reserved=2E
<=21-- END OF LEFT COLUMN-->
<=21-- END OF SUB-FOOTER BLOCK--><=21-- START OF BOTTOM TEASER BLOCK-->
3D=22img
<=21-- END OF BOTTOM TEASER BLOCK--><=21-- START OF FOOTER BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF FOOTER BLOCK-->